Literature DB >> 20548030

Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.

Eva-Jasmin Freyschmidt1, Clinton B Mathias, Natalia Diaz, Daniel H MacArthur, Amale Laouar, Narasimhaswamy Manjunath, Matthias D Hofer, Marc-Andre Wurbel, James J Campbell, Talal A Chatila, Hans C Oettgen.   

Abstract

Individuals with atopic dermatitis immunized with the small pox vaccine, vaccinia virus (VV), are susceptible to eczema vaccinatum (EV), a potentially fatal disseminated infection. Dysfunction of Forkhead box P3 (FoxP3)-positive regulatory T cells (Treg) has been implicated in the pathogenesis of atopic dermatitis. To test whether Treg deficiency predisposes to EV, we percutaneously VV infected FoxP3-deficient (FoxP3(KO)) mice, which completely lack FoxP3(+) Treg. These animals generated both fewer VV-specific CD8(+) effector T cells and IFN-gamma-producing CD8(+) T cells than controls, had higher viral loads, and exhibited abnormal Th2-polarized responses to the virus. To focus on the consequences of Treg deficiency confined to the skin, we generated mixed CCR4(KO) FoxP3(KO) bone marrow (CCR4/FoxP3) chimeras in which skin, but not other tissues or central lymphoid organs, lack Treg. Like FoxP3(KO) mice, the chimeras had impaired VV-specific effector T cell responses and higher viral loads. Skin cytokine expression was significantly altered in infected chimeras compared with controls. Levels of the antiviral cytokines, type I and II IFNs and IL-12, were reduced, whereas expression of the proinflammatory cytokines, IL-6, IL-10, TGF-beta, and IL-23, was increased. Importantly, infection of CCR4/FoxP3 chimeras by a noncutaneous route (i.p.) induced immune responses comparable to controls. Our findings implicate allergic skin inflammation resulting from local Treg deficiency in the pathogenesis of EV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20548030      PMCID: PMC3873154          DOI: 10.4049/jimmunol.0903144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population.

Authors:  Amanda J Reefer; Shama M Satinover; Michael D Solga; Joanne A Lannigan; Jennifer T Nguyen; Barbara B Wilson; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2008-01-04       Impact factor: 10.793

Review 2.  Role of Foxp3-positive regulatory T cells during infection.

Authors:  Yasmine Belkaid
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

3.  X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts.

Authors:  R W B Bottema; M Kerkhof; N E Reijmerink; G H Koppelman; C Thijs; F F Stelma; H A Smit; B Brunekreef; C P van Schayck; D S Postma
Journal:  Allergy       Date:  2009-12-21       Impact factor: 13.146

4.  IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.

Authors:  Susanna Lopez Kostka; Stephanie Dinges; Klaus Griewank; Yoichiro Iwakura; Mark C Udey; Esther von Stebut
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.

Authors:  Michiko K Oyoshi; Abdallah Elkhal; Lalit Kumar; Jordan E Scott; Suresh Koduru; Rui He; Donald Y M Leung; Michael D Howell; Hans C Oettgen; George F Murphy; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

6.  Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis.

Authors:  Yasunori Ito; Yuichi Adachi; Teruhiko Makino; Hiroyuki Higashiyama; Tatsuya Fuchizawa; Tadamichi Shimizu; Toshio Miyawaki
Journal:  Ann Allergy Asthma Immunol       Date:  2009-08       Impact factor: 6.347

7.  Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.

Authors:  Yuko Kawakami; Yoshiaki Tomimori; Kenji Yumoto; Shunji Hasegawa; Tomoaki Ando; Yutaka Tagaya; Shane Crotty; Toshiaki Kawakami
Journal:  J Exp Med       Date:  2009-05-25       Impact factor: 14.307

8.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

9.  Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity.

Authors:  Luzheng Liu; Qiong Zhong; Tian Tian; Krista Dubin; Shruti K Athale; Thomas S Kupper
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Foxp3+ regulatory T cells maintain immune homeostasis in the skin.

Authors:  Jan C Dudda; Nikole Perdue; Eva Bachtanian; Daniel J Campbell
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307

View more
  17 in total

Review 1.  Phenotypical and functional specialization of FOXP3+ regulatory T cells.

Authors:  Daniel J Campbell; Meghan A Koch
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 2.  Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.

Authors:  Kate S Smigiel; Shivani Srivastava; J Michael Stolley; Daniel J Campbell
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

3.  Smallpox vaccine safety is dependent on T cells and not B cells.

Authors:  Shari N Gordon; Valentina Cecchinato; Vibeke Andresen; Jean-Michel Heraud; Anna Hryniewicz; Robyn Washington Parks; David Venzon; Hye-kyung Chung; Tatiana Karpova; James McNally; Peter Silvera; Keith A Reimann; Hajime Matsui; Tomomi Kanehara; Yasuhiko Shinmura; Hiroyuki Yokote; Genoveffa Franchini
Journal:  J Infect Dis       Date:  2011-04-15       Impact factor: 5.226

4.  MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice.

Authors:  Magali Noval Rivas; Yi T Koh; Andrew Chen; Annie Nguyen; Young Ho Lee; Greg Lawson; Talal A Chatila
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

5.  Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.

Authors:  J T Low; P Hughes; A Lin; U Siebenlist; R Jain; K Yaprianto; D H D Gray; S Gerondakis; A Strasser; L A O'Reilly
Journal:  Immunol Cell Biol       Date:  2015-06-18       Impact factor: 5.126

6.  Chronic ethanol feeding induces subset loss and hyporesponsiveness in skin T cells.

Authors:  Corey P Parlet; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2014-02-11       Impact factor: 3.455

Review 7.  Advances in atopic dermatitis.

Authors:  Natalija Novak; Donald Y M Leung
Journal:  Curr Opin Immunol       Date:  2011-10-19       Impact factor: 7.486

8.  Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity.

Authors:  Xiaodong Jiang; Rachael A Clark; Luzheng Liu; Amy J Wagers; Robert C Fuhlbrigge; Thomas S Kupper
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

9.  IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.

Authors:  Tian Tian; Michelle Qiushuang Jin; Krista Dubin; Sandra L King; Wolfram Hoetzenecker; George F Murphy; Chen Amy Chen; Thomas S Kupper; Robert C Fuhlbrigge
Journal:  J Immunol       Date:  2017-05-03       Impact factor: 5.426

10.  IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection.

Authors:  Iwana Schmitz; Christoph Schneider; Anja Fröhlich; Helge Frebel; Daniel Christ; Warren J Leonard; Tim Sparwasser; Annette Oxenius; Stefan Freigang; Manfred Kopf
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.